Sleepiness Clinical Trials

6 recruiting

Sleepiness Trials at a Glance

14 actively recruiting trials for sleepiness are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Jacksonville, New York, and Cincinnati. Lead sponsors running sleepiness studies include Axsome Therapeutics, Inc., Centessa Pharmaceuticals (UK) Limited, and Athletic Greens International.

Browse sleepiness trials by phase

Treatments under study

About Sleepiness Clinical Trials

Looking for clinical trials for Sleepiness? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Sleepiness trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Sleepiness clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Impact of Bright Light Therapy on Prader-Willi Syndrome

Body WeightPrader-Willi SyndromeBehavior+3 more
Maimonides Medical Center50 enrolled1 locationNCT05939453
Recruiting
Not Applicable

Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea

Obstructive Sleep ApneaDaytime Sleepiness
Mayo Clinic40 enrolled1 locationNCT06395181
Recruiting
Phase 3

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc.508 enrolled13 locationsNCT07484217
Recruiting
Not Applicable

Promoting Teenage Sleep for Improved Mental Health and School Performance

InsomniaDepressionMental Health Issue+3 more
Kristianstad University3,000 enrolled1 locationNCT06306092
Recruiting
Not Applicable

Sleep and Morning Wellbeing Study

StressSleepRelaxation+1 more
Athletic Greens International300 enrolled1 locationNCT07311434
Recruiting
Not Applicable

Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness

Obstructive Sleep ApneaSleepiness
NYU Langone Health22 enrolled1 locationNCT06698809
Recruiting
Not Applicable

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm

SleepFatigueHumans+9 more
Region Skane300 enrolled1 locationNCT05107947
Recruiting
Phase 1

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Excessive Daytime Sleepiness
Centessa Pharmaceuticals (UK) Limited208 enrolled3 locationsNCT07082829
Recruiting
Phase 3

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Shift-work DisorderExcessive Sleepiness
Axsome Therapeutics, Inc.520 enrolled40 locationsNCT06568367
Recruiting
Not Applicable

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Quality of LifeElderlyCOPD+6 more
VA Office of Research and Development668 enrolled1 locationNCT04179981
Recruiting
Not Applicable

Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal

Obstructive Sleep Apnea (OSA)CPAP TreatmentCPAP+3 more
Stefan Lakämper54 enrolled1 locationNCT06872593
Recruiting

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

Obstructive Sleep Apnea (OSA)Excessive Daytime Sleepiness
Zealand University Hospital15 enrolled1 locationNCT06711159
Recruiting
Not Applicable

Effects of Delayed School Start Times on Sleep, Mental Health, and Academic Performance Among Norwegian Adolescents

SleepPsychiatric DisorderSleep Disorders, Circadian Rhythm+1 more
University of Bergen200 enrolled1 locationNCT06657482
Recruiting

Investigating Driver Sleepiness and Crash Risk in Young Drivers: A Randomized Control Trial to Optimise Sleep

Driver sleepinessSleep loss
Institute for Social Science Research - University of Queensland210 enrolled1 locationACTRN12621000132842